MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
- PMID: 36355327
- PMCID: PMC9941256
- DOI: 10.1007/s12094-022-02978-6
MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
Abstract
Cancer is frequently caused by microRNAs, which control post-transcriptional levels of gene expression by binding to target mRNAs. MiR-29a-3p has recently been shown to play a twofold function in the majority of malignancies, including colorectal cancer (CRC), according to mounting evidence. Here, we not only briefly summarize such connection between miR-29a-3p and cancers, but aslo primarily evaluate the miR-29a-3p expression pattern, clinical applicability, and molecular mechanisms in CRC to provide a guide for future studies. This review established the diagnostic and prognostic value of miR-29a-3p abnormalty in a variety of clinical samples for CRC. Furthermore, current molecular mechanisms of miR-29a-3p for regulating cancerous biological processes such growth, invasion, metastasis, the epithelial-mesenchymal transformation process, and immunomodulation through its upstream regulatory factors and downstream targeted genes were briefly explored. More specifically, miR-29a-3p has been linked to a few medications that have been shown to have anticancer benefits. To sum up, miR-29a-3p is a promising biomarker and prospective therapeutic target for the diagnosis and prognosis of CRC, but further research is still needed to establish a theoretical basis for more practical applications.
Keywords: Biomarker; Colorectal cancer; MiR-29a-3p; Molecular mechanisms; Therapeutic target.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Downregulation of RPS15A by miR-29a-3p attenuates cell proliferation in colorectal carcinoma.Biosci Biotechnol Biochem. 2019 Nov;83(11):2057-2064. doi: 10.1080/09168451.2019.1637712. Epub 2019 Jul 13. Biosci Biotechnol Biochem. 2019. PMID: 31303129
-
Abstracts of Presentations at the Association of Clinical Scientists 143rd Meeting Louisville, KY May 11-14,2022.Ann Clin Lab Sci. 2022 May;52(3):511-525. Ann Clin Lab Sci. 2022. PMID: 35777803 No abstract available.
-
LncRNA testis-specific transcript, Y-linked 15 (TTTY15) promotes proliferation, migration and invasion of colorectal cancer cells via regulating miR-29a-3p/DVL3 axis.Cancer Biomark. 2021;31(1):1-11. doi: 10.3233/CBM-201709. Cancer Biomark. 2021. PMID: 33016900
-
Prognostic value of lncRNA HOXA-AS3 in cervical cancer by targeting miR-29a-3p and its regulatory effect on tumor progression.J Obstet Gynaecol Res. 2022 Oct;48(10):2594-2602. doi: 10.1111/jog.15360. Epub 2022 Jul 11. J Obstet Gynaecol Res. 2022. PMID: 35817473
-
Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.J Transl Med. 2017 Dec 19;15(1):257. doi: 10.1186/s12967-017-1357-7. J Transl Med. 2017. PMID: 29258530 Free PMC article.
References
-
- Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer Lancet Lond Engl. 2019;394:1467–1480. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical